(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, life sciences services company IQVIA Holdings Inc. (IQV) initiated its adjusted earnings and revenue guidance for the full-year 2025.
For fiscal 2025, the company now projects adjusted earnings in a range of $11.70 to $12.10 per share on revenues between $15.725 billion and $16.125 billion.
On average, 23 analysts polled by Thomson Reuters expect earnings of $11.88 per share on revenues of $16.03 billion for the year. Analysts' estimates typically exclude special items.
This revenue guidance assumes just over $100 million of COVID-related revenue step-down, entirely in R&DS, approximately 150 basis points of headwind from foreign exchange, and 100-150 basis points of contribution from acquisitions.
The company reaffirms its 2025 outlook of revenue growth at constant currency ex-COVID of 4 to 7 percent, adjusted EBITDA margin expansion of up to 20 basis points and adjusted earnings per share growth of 5 to 9 percent.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
